URMC Begins Clinical Trial for New COVID-19 Treatment

The University of Rochester Medical Center (URMC) is participating in a NIH-sponsored clinical trial to evaluate the safety and efficacy of the investigational antiviral drug remdesivir in hospitalized adults diagnosed with COVID-19.

Source: University of Rochester Medical Center Press Releases - March 25, 2020 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news